Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Anatomic dead space refers to the volume of the *conducting airways* (nose, mouth, pharynx, larynx, trachea, bronchi, and terminal bronchioles) that carries air to the alveoli but does not itself participate in gas exchange[1][2][3][4][5][6][7][8]. Normally, this space amounts to about 150 mL in adults or about 2 mL/kg of body weight, corresponding to roughly one-third of an average tidal volume[1][2][5][7][8]. Air in the anatomic dead space is exhaled unchanged as it has not come into contact with the alveolar-capillary membrane. The concept is clinically relevant in ventilation management and can impact the effectiveness of mechanical ventilation. It is also important in diseases causing ventilation-perfusion mismatch, as the distinction between anatomical and physiological dead space becomes critical[3][4][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Anatomic dead space.